Statin Use and the Risk of Prostate Cancer in Ischemic Heart Disease Patients in Taiwan

Clinical Pharmacology and Therapeutics
Wei HoZhen-Fang Lin

Abstract

Patients with ischemic heart disease (IHD) are more likely to be diagnosed with prostate cancer. Statins, which are widely used in such patients, are shown to modify the risk of prostate cancer. To clarify the association between statin use and the risk of prostate cancer among patients with higher risk of developing prostate cancer in Taiwan, a cohort of 26,628 men with IHD and aged between 55 and 100 were acquired from the National Health Insurance Research Database and followed over a period of 8 years. The risk of prostate cancer was calculated by time-dependent Cox regression model. Statin use was associated with significantly lower risk of both total and advanced prostate cancer (adjusted hazard ratio (HR): 0.719, 95% confidence interval (CI): 0.570-0.908; adjusted HR: 0.718, 95% CI: 0.530-0.972 respectively). In Taiwan IHD population, the reduction in risk of prostate cancer was observed in statin users as compared with nonusers.

References

Feb 16, 1994·Journal of the National Cancer Institute·P H GannM J Stampfer
Mar 10, 1999·Journal of the National Cancer Institute·L N KolonelR V Cooney
Dec 18, 2001·British Journal of Cancer·V BagnardiG Corrao
Feb 13, 2002·Circulation·Michael WeisJohn P Cooke
Jun 26, 2002·Neoplasia : an International Journal for Oncology Research·Jim DimitroulakosSuzanne Kamel-Reid
Mar 1, 2003·Biophysical Journal·Jared C LawrenceRobert M Henderson
Nov 9, 2004·Cancer Treatment Reviews·Matthijs R GraafHenk-Jan Guchelaar
Oct 4, 2005·Clinical Pharmacology and Therapeutics·Edmund LeeDennis Schneck
Dec 21, 2006·Journal of the National Cancer Institute·Elizabeth A PlatzEdward Giovannucci
Oct 19, 2007·Pharmacoepidemiology and Drug Safety·Gary D FriedmanLaurel A Habel
Nov 17, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Teemu J MurtolaAnssi Auvinen
Jan 18, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ashraful HoqueXiao-Chun Xu
May 21, 2008·International Journal of Cancer. Journal International Du Cancer·Stefanos BonovasNikolaos M Sitaras
Aug 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jaana KuoppalaEero Pukkala
Oct 30, 2008·Journal of the National Cancer Institute·Robert J HamiltonStephen J Freedland
Jun 23, 2009·International Journal of Cancer. Journal International Du Cancer·Hiroyasu IsoUNKNOWN JPHC Study Group
Jul 14, 2010·The Journal of Urology·Rodney H BreauJennifer L St Sauver
Aug 13, 2010·The Annals of Pharmacotherapy·Devin M MannIan Kronish
Nov 5, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F BrayA Auvinen
Feb 1, 2011·Public Health·W S Welfare, L Lighton
Apr 12, 2011·The Prostate·Chih-Ching ChangChun-Yuh Yang
Jul 30, 2011·The Urologic Clinics of North America·Keith R Solomon, Michael R Freeman
Nov 23, 2011·Pharmacological Reviews·Patrizia GazzerroMaurizio Bifulco
Feb 9, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jean-Alfred ThomasStephen J Freedland
Oct 11, 2012·PloS One·Dipika BansalFabrizio Schifano
Apr 10, 2013·Prostate Cancer and Prostatic Diseases·S J FreedlandR S Rittmaster
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Nov 28, 2013·Cancer Epidemiology·Christina G JespersenMichael Borre
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 16, 2016·Circulation·Ryan J KoeneSuma H Konety
Oct 7, 2016·International Journal of Cardiology·Mi Seon JiUNKNOWN other Korea Acute Myocardial Infarction Registry Investigators
Nov 3, 2016·Nature Reviews. Urology·Mahmoud A AlfaqihStephen J Freedland
Mar 1, 2017·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Yi-Heng LiUNKNOWN Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients

❮ Previous
Next ❯

Citations

Apr 26, 2019·Cells·Omar Salem, Carsten G Hansen
Mar 5, 2021·Clinics and Research in Hepatology and Gastroenterology·Liusheng LiWu Yu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved